BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/18/2023 5:48:01 AM | Browse: 282 | Download: 817
 |
Received |
|
2022-09-18 09:46 |
|
Peer-Review Started |
|
2022-09-18 09:48 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-10-20 07:36 |
|
Revised |
|
2022-11-04 12:18 |
|
Second Decision |
|
2022-12-14 04:07 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-12-14 17:42 |
|
Articles in Press |
|
2022-12-14 17:42 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2022-12-02 00:45 |
|
Typeset the Manuscript |
|
2022-12-19 06:54 |
|
Publish the Manuscript Online |
|
2023-01-18 05:48 |
| ISSN |
1948-9366 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Prognostic effect of excessive chemotherapy cycles for stage II and III gastric cancer patients after D2 + gastrectomy
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yi-Fan Li, Wen-Bing Zhang and Yu-Ye Gao |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Yi-Fan Li, MD, Chief Doctor, Surgeon, Department of General Surgery, Shanxi Cancer Hospital, No. 3 Xinghualing District，Staff New Village, Taiyuan 030013, Shanxi Province, China. lyf8028@126.com |
| Key Words |
Gastric cancer; Propensity score matching; Chemotherapy cycles; Overall survival; Progression-free survival; Recurrence |
| Core Tip |
This retrospective study determined the survival benefit of excess chemotherapy cycles for gastric cancer after D2 gastrectomy. No difference in progression-free survival and overall survival was observed between patients receiving ≥ 9 or < 9 cycles of chemotherapy. Stage III gastric cancer patients receiving ≥ 9 cycles of chemotherapy had significantly lower overall recurrence, local-regional metastasis, and distant metastasis. The Cox proportional risk regression model was used in the exploration and analysis that intestinal type, proximal gastrectomy, and ≥ 6 cm maximum tumor diameter had a higher risk of total mortality in the < 9 cycles of chemotherapy group. |
| Publish Date |
2023-01-18 05:48 |
| Citation |
Li YF, Zhang WB, Gao YY. Prognostic effects of excessive chemotherapy cycles for stage II and III gastric cancer patients after D2 + gastrectomy. World J Gastrointest Surg 2023; 15(1): 32-48 |
| URL |
https://www.wjgnet.com/1948-9366/full/v15/i1/32.htm |
| DOI |
https://dx.doi.org/10.4240/wjgs.v15.i1.32 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
